Employing Adaptive Approaches to Reach Desired Clinical Objectives

The field of oncology is expanding and changing rapidly. With increasing advancements in genomics and interests in precision-based medicine, more biomarker-guided treatments are being tested for new indications at an increasing rate. Jay JH Park, Adam Hamm and Ofir Harari at Cytel Inc. show how you can overcome clinical development challenges in oncology by using adaptive and innovative trial design.